Recent Updates
Recently added Catalysts
MTD

METTLER-TOLEDO INTERNATIONAL INC. REPORTS FOURTH QUARTER 2018 RESULTS - - Excellent Sales Growth - - - - Strong Earnings Growth - - COLUMBUS, Ohio, USA

Key Takeaway: METTLER-TOLEDO INTERNATIONAL INC. REPORTS FOURTH QUARTER 2018 RESULTS - - Excellent Sales Growth - - - - Strong Earnings Growth - - COLUMBUS, Ohio, USA - February 7, 2019 - Mettler-Toledo International Inc. (NYSE: MTD) today announced fourth quarter results for 2018. Provided

Full Press Release Details

METTLER-TOLEDO INTERNATIONAL INC. REPORTS
FOURTH QUARTER 2018 RESULTS
- - Excellent Sales Growth - -
- - Strong Earnings Growth - -
COLUMBUS, Ohio, USA - February 7, 2019 - Mettler-Toledo International Inc. (NYSE: MTD) today announced fourth quarter results for 2018. Provided below are the highlights:
Fourth Quarter Results
Olivier Filliol, President and Chief Executive Officer, stated, "We achieved excellent sales growth in the quarter with very good results in most of our Laboratory and Industrial product lines. China had another quarter of strong sales growth. We benefited from our productivity and margin initiatives, and despite adverse currency and higher tariff costs, recognized a strong increase in operating margins and earnings growth."
EPS in the quarter was $7.11, compared with the prior-year amount of $2.93. Included in 2018 EPS is a one-time non-cash acquisition-related gain of $0.75 and included in 2017 EPS is a tax charge of $2.74. Additional details on one-time items included in EPS are found in the attached schedules.
Compared with the prior year, total reported sales increased 5% to $817.9 million. By region, reported sales increased 6% in the Americas, 3% in Europe and 7% in Asia/Rest of World. Earnings before tax amounted to $230.5 million, compared with $193.9 million in the prior year.
Adjusted EPS was $6.85, an increase of 15% over the prior-year amount of $5.97.
Compared with the prior year, total sales in local currency increased 8% as currency reduced reported sales growth by 3%. By region, local currency sales increased 7% in the Americas, 6% in Europe and 10% in Asia/Rest of World. Adjusted Operating Income amounted to $239.7 million, an 11% increase from the prior-year amount of $216.9 million.
Adjusted EPS and Adjusted Operating Income are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.
EPS in 2018 was $19.88, compared with the prior-year amount of $14.24. Included in 2018 EPS is a one-time non-cash acquisition-related gain of $0.74 and included in 2017 EPS is a tax charge of $2.73. Additional details on one-time items included in EPS are found in the attached schedules.
Total reported sales increased 8% in 2018 to $2.936 billion. By region, reported sales increased 5% in the Americas, 7% in Europe and 12% in Asia/Rest of World. Earnings before tax amounted to $651.9 million, compared with $574.2 million in the prior year.
Adjusted EPS was $20.32, an increase of 16% over the prior-year amount of $17.57.
Total sales in local currency increased 6% in 2018 as currency benefited reported sales growth by 2%. By region, local currency sales increased 5% in the Americas, 4% in Europe and 10% in Asia/Rest of World. Adjusted Operating Income amounted to $730.5 million, a 12% increase from the prior-year amount of $652.6 million.
Adjusted EPS and Adjusted Operating Income are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.
The Company said that based on its assessment of market conditions today, management anticipates local currency sales growth in 2019 will be approximately 5%. This sales growth is expected to result in Adjusted EPS in the range of $22.50 to $22.70, a growth rate of 11% to 12%. Previously, the Company provided guidance for Adjusted EPS in the range of $22.40 to $22.60.
Based on today's assessment of market conditions, management anticipates that local currency sales growth in the first quarter 2019 will be approximately 5.5%, and Adjusted EPS is forecasted to be in the range of $4.00 to $4.05, an increase of 7% to 8%.
While the Company has provided an outlook for local currency sales growth and Adjusted EPS, it has not provided an outlook for reported sales growth or EPS as it would require an estimate of currency exchange fluctuations and non-recurring items, which are not yet known. The Company noted in making its outlook that economic uncertainty remains in certain regions of the world and market conditions are subject to change.
Filliol concluded, "We ended 2018 on a positive note as demand in our markets remains solid and our growth initiatives continue to yield strong results. We are cautious on the global economy as uncertainties exist, particularly concerning trade tariff disputes. We will continue to monitor developments closely and adapt our plans if economic conditions change. We assume market conditions will remain favorable and are confident in our ability to execute on our growth initiatives. With the benefit of our investments in our field force, Spinnaker sales and marketing programs and new product launches, we believe we are well positioned to continue to gain market share. With the positive impact from margin and productivity initiatives and, despite headwinds due to currency and tariffs, we believe we can deliver strong results in 2019."
The Company will host a conference call to discuss its quarterly results today (Thursday, Feb. 7) at 4:30 p.m. Eastern Time. To hear a live webcast or replay of the call, visit the investor relations page on the Company's website at www.mt.com/investors. The presentation referenced in the conference call will be located on the website prior to the call.
METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control and manufacturing processes for customers in a wide range of industries including life sciences, food and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.
Statements in this press release which are not historical facts constitute "forward-looking statements" within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. These statements involve known and unknown risks, uncertainties and other factors that may cause our or our businesses' actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential"
or "continue" or the negative of those terms or other comparable terminology. For a discussion of these risks and uncertainties, please see the discussion on forward-looking statements in our current report on Form 10-K. All of the forward-looking statements are qualified in their entirety by reference to the factors discussed under the caption "Factors affecting our future operating results" and in the "Business" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of our annual report on Form 10-K for the most recently completed fiscal year, which describe risks and factors that could cause results to differ materially from those projected in those forward-looking statements.
METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS (amounts in thousands except share data) (unaudited)
Three Months Ended Three Months Ended
December 31, 2018 % of sales December 31, 2017 % of sales
Net sales $ 817,923 (a) 100.0 $ 778,031 100.0
Cost of sales 340,357 41.6 322,256 (b) 41.4
Gross profit 477,566 58.4 455,775 58.6
Research and development 36,205 4.4 32,324 (b) 4.2
Selling, general and administrative 201,653 24.7 206,547 (b) 26.5
Amortization 11,963 1.5 11,661 1.5
Interest expense 8,840 1.1 8,625 1.1
Restructuring charges 4,464 0.5 3,932 0.5
Other charges (income), net (16,013 ) (2.0) (1,214 ) (b) (0.1)
Earnings before taxes 230,454 28.2 193,900 24.9
Provision for taxes 49,268 (c) 6.0 116,924 (c) 15.0
Net earnings $ 181,186 22.2 $ 76,976 9.9
Basic earnings per common share:
Net earnings $ 7.25 $ 3.01
Weighted average number of common shares 24,975,303 25,562,542
Diluted earnings per common share:
Net earnings $ 7.11 $ 2.93
Weighted average number of common and common equivalent shares 25,490,270 26,229,052
Note:
(a) Local currency sales increased 8% as compared to the same period in 2017.
(b) In accordance with the new accounting rules that went into effect January 1, 2018, the Company reclassified a net pension benefit of $0.9 million into other charges (income) from other income statement categories for the three months ended December 31, 2017 to be consistent with 2018 presentation.
(c) Provision for taxes includes charges of $3.6 million and $72 million for the three months ended December 31, 2018 and 2017, respectively, for the implementation of the Tax Cuts and Jobs Act.
RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING INCOME
Three Months Ended Three Months Ended
December 31, 2018 % of sales December 31, 2017 % of sales
Earnings before taxes $ 230,454 $ 193,900
Amortization 11,963 11,661
Interest expense 8,840 8,625
Restructuring charges 4,464 3,932
Other charges (income), net (16,013 ) (d) (1,214 )
Adjusted operating income $ 239,708 (e) 29.3 $ 216,904 27.9
Note:
(d) Other charges (income), net includes a one-time gain of $18.7 million relating to the Biotix acquisition contingent consideration and a one-time legal charge of $3.0 million for the three months ended December 31, 2018.
(e) Adjusted operating income increased 11% as compared to the same period in 2017.
METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS (amounts in thousands except share data) (unaudited)
Twelve Months Ended Twelve Months Ended
December 31, 2018 % of sales December 31, 2017 % of sales
Net sales $ 2,935,586 (a) 100.0 $ 2,725,053 100.0
Cost of sales 1,251,208 42.6 1,149,302 (b) 42.2
Gross profit 1,684,378 57.4 1,575,751 57.8
Research and development 141,071 4.8 128,308 (b) 4.7
Selling, general and administrative 812,802 27.7 794,861 (b) 29.2
Amortization 47,524 1.6 42,671 1.6
Interest expense 34,511 1.2 32,785 1.2
Restructuring charges 18,420 0.6 12,772 0.5
Other charges (income), net (21,808 ) (0.7 ) (9,868 ) (b) (0.5 )
Earnings before taxes 651,858 22.2 574,222 21.1
Provision for taxes 139,247 (c) 4.7 198,250 (c) 7.2
Net earnings $ 512,611 17.5 $ 375,972 13.8
Basic earnings per common share:
Net earnings $ 20.33 $ 14.62
Weighted average number of common shares 25,215,674 25,713,575
Diluted earnings per common share:
Net earnings $ 19.88 $ 14.24
Weighted average number of common and common equivalent shares 25,781,324 26,393,783
Note:
(a) Local currency sales increased 6% as compared to the same period in 2017.
(b) In accordance with the new accounting rules that went into effect on January 1, 2018, the Company reclassified a net pension benefit of $4.0 million into other charges (income) from other income statement categories for the twelve months ended December 31, 2017 to be consistent with 2018 presentation.
(c) Provision for taxes includes charges of $3.6 million and $72 million for the twelve months ended December 31, 2018 and 2017, respectively, for the implementation of the Tax Cuts and Jobs Act.
RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING INCOME
Twelve Months Ended Twelve Months Ended
December 31, 2018 % of sales December 31, 2017 % of sales
Earnings before taxes $ 651,858 $ 574,222
Amortization 47,524 42,671
Interest expense 34,511 32,785
Restructuring charges 18,420 12,772
Other charges (income), net (21,808 ) (d) (9,868 ) (f)
Adjusted operating income $ 730,505 (e) 24.9 $ 652,582 23.9
Note:
(d) Other charges (income), net includes a one-time gain of $18.7 million relating to the Biotix acquisition contingent consideration and a one-time legal charge of $3.0 million for the twelve months ended December 31, 2018.
(e) Adjusted operating income increased 12% as compared to the same period in 2017.
(f) Other charges (income), net includes a one-time gain of $3.4 million relating to the sale of a facility in Switzerland in connection with our initiative to consolidate certain Swiss operations into a new facility and $1.7 million of acquisition costs for the twelve months ended December 31, 2017.
METTLER-TOLEDO INTERNATIONAL INC. CONDENSED CONSOLIDATED BALANCE SHEETS (amounts in thousands) (unaudited)
December 31, 2018 December 31, 2017
Cash and cash equivalents $ 178,110 $ 148,687
Accounts receivable, net 535,528 528,615
Inventories 268,821 255,390
Other current assets and prepaid expenses 63,401 74,031
Total current assets 1,045,860 1,006,723
Property, plant and equipment, net 717,526 668,271
Goodwill and other intangible assets, net 752,088 766,556
Other non-current assets 103,373 108,255
Total assets $ 2,618,847 $ 2,549,805
Short-term borrowings and maturities of long-term debt $ 49,670 $ 19,677
Trade accounts payable 196,641 167,627
Accrued and other current liabilities 488,123 502,369
Total current liabilities 734,434 689,673
Long-term debt 985,021 960,170
Other non-current liabilities 309,329 352,682
Total liabilities 2,028,784 2,002,525
Shareholders' equity 590,063 547,280
Total liabilities and shareholders' equity $ 2,618,847 $ 2,549,805
METTLER-TOLEDO INTERNATIONAL INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (amounts in thousands) (unaudited)
Three months ended Twelve months ended
December 31, December 31,
2018 2017 2018 2017
Cash flow from operating activities:
Net earnings $ 181,186 $ 76,976 $ 512,611 $ 375,972
Adjustments to reconcile net earnings to
net cash provided by operating activities:
Depreciation 9,278 9,037 37,167 33,458
Amortization 11,963 11,661 47,524 42,671
Deferred tax provision (benefit) 14,203 5,009 2,302 (2,745 )
Share-based compensation 5,074 4,759 17,579 16,582
U.S. tax reform charge (a) 3,597 71,982 3,597 71,982
Acquisition gain (b) (18,674 ) - (18,674 ) -
Gain on facility sale - - - (3,394 )
Other 147 16 (2,559 ) 243
Decrease in cash resulting from changes in
operating assets and liabilities (8,202 ) (14,350 ) (34,542 ) (18,444 )
Net cash provided by operating activities 198,572 165,090 565,005 516,325
Cash flows from investing activities:
Proceeds from sale of property, plant and equipment 381 1,536 8,190 11,973
Purchase of property, plant and equipment (46,061 ) (41,600 ) (142,726 ) (127,426 )
Acquisitions (565 ) - (5,527 ) (108,445 )
Net hedging settlements on intercompany loans 1,899 2,838 1,119 6,554
Net cash used in investing activities (44,346 ) (37,226 ) (138,944 ) (217,344 )
Cash flows from financing activities:
Proceeds from borrowings 168,341 258,501 940,615 1,244,195
Repayments of borrowings (172,620 ) (351,111 ) (876,324 ) (1,185,172 )
Proceeds from exercise of stock options 9,823 5,334 24,600 28,649
Repurchases of common stock (118,750 ) (64,999 ) (474,999 ) (399,997 )
Other financing activities (250 ) - (1,914 ) (7,205 )
Net cash used in financing activities (113,456 ) (152,275 ) (388,022 ) (319,530 )
Effect of exchange rate changes on cash and cash equivalents (108 ) 4,012 (8,616 ) 10,562
Net increase (decrease) in cash and cash equivalents 40,662 (20,399 ) 29,423 (9,987 )
Cash and cash equivalents:
Beginning of period 137,448 169,086 148,687 158,674
End of period $ 178,110 $ 148,687 $ 178,110 $ 148,687
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW
Net cash provided by operating activities $ 198,572 $ 165,090 $ 565,005 $ 516,325
Payments in respect of restructuring activities 4,119 4,962 20,820 12,663
Payments for acquisition costs 233 672 375 1,436
Transition tax payment - - 4,200 -
Proceeds from sale of property, plant and equipment 381 1,536 8,190 11,973
Purchase of property, plant and equipment (46,061 ) (41,600 ) (142,726 ) (127,426 )
Adjusted free cash flow $ 157,244 $ 130,660 $ 455,864 $ 414,971
(a) Represents U.S. tax reform charges of $3.6 million and $72 million for the three and twelve months ended December 31, 2018 and 2017, respectively, for the implementation of the Tax Cuts and Jobs Act.
(b) Represents a one-time gain of $18.7 million relating to the Biotix acquisition contingent consideration for the three and twelve months ended December 31, 2018.
METTLER-TOLEDO INTERNATIONAL INC. OTHER OPERATING STATISTICS
SALES GROWTH BY DESTINATION
(unaudited)
Europe Americas Asia/RoW Total
U.S. Dollar Sales Growth
Three Months Ended December 31, 2018 3 % 6 % 7 % 5 %
Twelve Months Ended December 31, 2018 7 % 5 % 12 % 8 %
Local Currency Sales Growth
Three Months Ended December 31, 2018 6 % 7 % 10 % 8 %
Twelve Months Ended December 31, 2018 4 % 5 % 10 % 6 %
RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS
(unaudited)
Three months ended Twelve months ended
December 31, December 31,
2018 2017 % Growth 2018 2017 % Growth
EPS as reported, diluted $ 7.11 $ 2.93 143% $ 19.88 $ 14.24 40%
Restructuring charges, net of tax 0.14 (a) 0.12 (a) 0.56 (a) 0.38 (a)
Purchased intangible amortization, net of tax 0.10 (b) 0.09 (b) 0.39 (b) 0.27 (b)
U.S. tax reform 0.14 (c) 2.74 (c) 0.14 (c) 2.73 (c)
Income tax expense 0.02 (d) 0.09 (d) - -
Acquisition (gain) costs, net of tax (0.75 ) (e) - (0.74 ) (e) 0.05 (e)
Legal charge, net of tax 0.09 (f) - 0.09 (f) -
Gain on facility sale - - - (0.10 ) (g)
Adjusted EPS, diluted $ 6.85 $ 5.97 15% $ 20.32 $ 17.57 16%
Notes:
(a) Represents the EPS impact of restructuring charges of $4.5 million ($3.5 million after tax) and $3.9 million ($3.1 million after tax) for the three months ended December 31, 2018 and 2017, and $18.4 million ($14.5 million after tax) and $12.8 million ($10.0 million after tax) for the twelve months ended December 31, 2018 and 2017, respectively, which primarily include employee related costs.
(b) Represents the EPS impact of purchased intangibles amortization of $3.3 million ($2.5 million after tax) and $3.7 million ($2.3 million after tax) for the three months ended December 31, 2018 and 2017, and $13.3 million ($10.0 million after tax) and $10.9 million ($7.1 million after tax) for the twelve months ended December 31, 2018 and 2017, respectively.
(c) Represents the EPS impact of U.S. tax reform charges of $3.6 million and $72.0 million for the three and twelve months ended December 31, 2018 and 2017, respectively, for the implementation of the Tax Cuts and Jobs Act.
(d) Represents the EPS impact of the difference between our quarterly and annual tax rate from excess tax benefits associated with stock option exercises.
(e) Represents the EPS impact of a one-time gain of $18.7 million ($19.2 million after tax) for the three and twelve months ended December 31, 2018 associated with the Biotix acquisition contingent consideration. Amounts for the twelve months ended December 31, 2017 represent the EPS impact of acquisition costs of $1.7 million ($1.3 million after tax).
(f) Represents the EPS impact of a one-time legal charge of $3.0 million ($2.4 million after tax) for the three and twelve months ended December 31, 2018.
(g) Represents the EPS impact of a one-time gain of $3.4 million ($2.7 million after tax) for the twelve months ended December 31, 2017 relating to the sale of a facility in Switzerland in connection with our initiative to consolidate certain Swiss operations into a new facility.
Last updated: Feb 7, 2019